Please assess the completion status of the following clinical trial:

Trial Title: Kypho-IORT vs. EBRT in Spinal Metastases

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 50 years~* Karnofsky Index ≥ 60~* Initial pain score using the VAS ≥ 3 under standard pain medication~* Histological or by imaging proven painful osteolytic metastases (max. 4 treatable vertebrae) of the thoracic/lumbar spine, which are accessible for Kypho-IORT~* Written informed consent obtained~* Exclusion Criteria:~* Previous local treatment (irradiation, surgery)~* Cranial site of the metastasis above T4~* Pathological fracture with sintering \>50%~* Purely osteoblastic metastasis~* Intraspinal extension~* Erosion of the bony borders of the vertebra which make a cement filling difficult, rated by the treating surgeon~* Tumor expansion to dorsal vertebral structures (pedicle, lamina)~* Pregnancy/lactation

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm A: Kypho-IORT (Type: EXPERIMENTAL): balloon kyphoplasty/vertebroplasty + intraoperative radiotherapy
- Arm B: EBRT (Type: ACTIVE_COMPARATOR): external beam radiotherapy with 30 Gy during 10 days (3 Gy/day)

Based on this trial design, predict the completion outcome and termination type (if applicable).